Abstract:ObjectiveTo explore the safety and feasibility of transvaginal delivery in scarred uterus in a full-term pregnancy.MethodsFrom January to December 2016,89 pregnant women with scarred uterus delivered in our hospital were selected.According to the principle of voluntariness,they were divided into vaginal trial group and cesarean section group.Meanwhile,40 healthy pregnant women without scarred uterus who gave delivery in our hospital were selected during the same period and categorized into non-scarred uterus group.The postpartum 24 h bleeding,labor time,hospital stay,neonatal conditions,and puerperal infection in pregnant women among three groups were compared.ResultsSixtyfour pregnant women tried vaginal trial,and 17 cases were failed and turned to cesarean section,which were classified into the cesarean section group.The number of the final vaginal delivery was 47 cases,and the success rate of vaginal trial was 73.44%.There were 42 cases and 40 cases in the cesarean section group and non-scarred uterus group respectively.The indexes of hospital stay,amount of bleeding 24 h after delivery,neonatal Apgar score,puerperal infection,and labor time in the vaginal delivery group were greatly superior to those in the cesarean section group with statistical differences(P<0.05).No statistical difference was displayed in labor time,hospital stay,amount of bleeding 24 h after delivery,puerperal infection,and neonatal Apgar score after comparing with those in the non-scarred uterus group (P>0.05).ConclusionIn comparison with delivery by cesarean section,a second-time transvaginal delivery in scarred uterus can effectively improve outcomes in pregnancy and neonates.Under the strict control of indications of vaginal delivery,opportunity for vaginal trial delivery in pregnant women should be provided.
王爱桃;邓菊香;王立群;邓覃;王红丽;黎阳. 瘢痕子宫再次足月妊娠经阴道分娩的评估与可行性分析[J]. 中国当代医药, 2017, 24(23): 102-104.
WANG Ai-tao;DENG Ju-xiang;WANG Li-qun;DENG Qin;WANG Hong-li;LI Yang. Evaluation of a second-time transvaginal delivery in scarred uterus in a full-term pregnancy and its feasibility analysis. 中国当代医药, 2017, 24(23): 102-104.